Keros Therapeutics
KROS
KROS
49 hedge funds and large institutions have $454M invested in Keros Therapeutics in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 8 closing their positions.
Holders
49
Holders Change
-2
Holders Change %
-3.92%
% of All Funds
0.99%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
6
Increased
17
Reduced
15
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EC
51
EcoR1 Capital
San Francisco,
California
| – | – | -220,216 | Closed |
|
52
Citadel Advisors
Miami,
Florida
| – | – | -157,333 | Closed |
|
|
ZP
53
Zimmer Partners
New York
| – | – | -15,889 | Closed |
|
54
Jane Street
New York
| – | – | -10,397 | Closed |
|
55
SG Americas Securities
New York
| – | – | -4,087 | Closed |
|
56
UBS Group
Zurich,
Switzerland
| – | – | -2,207 | Closed |
|
|
PFO
57
Pathstone Family Office
Englewood,
New Jersey
| – | – | -1,267 | Closed |
|
|
CFGS
58
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|